Vertebral artery aneurysms and the risk of cord infarction following spinal artery coverage during flow diversion.


Journal

Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357

Informations de publication

Date de publication:
27 Mar 2020
Historique:
received: 06 12 2019
accepted: 08 01 2020
pubmed: 29 3 2020
medline: 31 7 2021
entrez: 29 3 2020
Statut: epublish

Résumé

Coverage of the anterior spinal artery (ASA) ostia is a source of considerable consternation regarding flow diversion (FD) in vertebral artery (VA) aneurysms due to cord supply. The authors sought to assess the association between coverage of the ASA, posterior spinal artery (PSA), or lateral spinal artery (LSA) ostia when placing flow diverters in distal VAs and clinical outcomes, with emphasis on cord infarction. A multicenter retrospective study of 7 institutions in which VA aneurysms were treated with FD between 2011 and 2019 was performed. The authors evaluated the risk of ASA and PSA/LSA occlusion, associated thromboembolic complication, complications overall, aneurysm occlusion status, and functional outcome. Sixty patients with 63 VA and posterior inferior cerebellar artery aneurysms treated with FD were identified. The median aneurysm diameter was 7 mm and fusiform type was the commonest morphology (42.9%). During a procedure, 1 (61.7%) or 2 (33.3%) flow diverters were placed. Complete occlusion was achieved in 71.9%. Symptomatic thromboembolic complications occurred in 7.4% of cases and intracranial hemorrhage in 10.0% of cases. The ASA and PSA/LSA were identified in 51 (80.9%) and 35 (55.6%) complications and covered by the flow diverter in 29 (56.9%) and 13 (37.1%) of the procedures, respectively. Patency after flow diverter coverage on last follow-up was 89.2% for ASA and 100% for PSA/LSA, not significantly different between covered and noncovered groups (p = 0.5 and p > 0.99, respectively). No complications arose from coverage. FD aneurysm treatment in the posterior circulation with coverage of ASA or PSA/LSA was not associated with higher rates of occlusion of these branches or any instances of cord infarction.

Identifiants

pubmed: 32217800
doi: 10.3171/2020.1.JNS193293
pii: 2020.1.JNS193293
doi:
pii:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

961-970

Auteurs

Adam A Dmytriw (AA)

1Division of Diagnostic and Therapeutic Neuroradiology, St. Michael's Hospital, Toronto.
2Department of Medical Imaging & Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
3Neurosurgery & Neuroradiology Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Anish Kapadia (A)

1Division of Diagnostic and Therapeutic Neuroradiology, St. Michael's Hospital, Toronto.
2Department of Medical Imaging & Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Alejandro Enriquez-Marulanda (A)

3Neurosurgery & Neuroradiology Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Carmen Parra-Fariñas (C)

1Division of Diagnostic and Therapeutic Neuroradiology, St. Michael's Hospital, Toronto.

Anna Luisa Kühn (AL)

3Neurosurgery & Neuroradiology Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Patrick J Nicholson (PJ)

2Department of Medical Imaging & Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Muhammad Waqas (M)

5Department of Neurosurgery, State University of New York at Buffalo, New York.

Leonardo Renieri (L)

6Department of Interventional Neuroradiology, University of Florence, Italy.

Caterina Michelozzi (C)

7Department of Neurosurgery, University of Alabama at Birmingham, Alabama.

Paul M Foreman (PM)

4Orlando Health, Neuroscience and Rehabilitation Institute, Orlando, Florida.

Kevin Phan (K)

3Neurosurgery & Neuroradiology Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

I-Hsiao Yang (IH)

2Department of Medical Imaging & Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
8Department of Medical Imaging, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

Vincent M Tutino (VM)

5Department of Neurosurgery, State University of New York at Buffalo, New York.

Christopher S Ogilvy (CS)

1Division of Diagnostic and Therapeutic Neuroradiology, St. Michael's Hospital, Toronto.

Ivan Radovanovic (I)

2Department of Medical Imaging & Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Mark R Harrigan (MR)

7Department of Neurosurgery, University of Alabama at Birmingham, Alabama.

Adnan H Siddiqui (AH)

5Department of Neurosurgery, State University of New York at Buffalo, New York.

Elad I Levy (EI)

5Department of Neurosurgery, State University of New York at Buffalo, New York.

Nicola Limbucci (N)

6Department of Interventional Neuroradiology, University of Florence, Italy.

Christophe Cognard (C)

9Department of Diagnostic and Therapeutic Neuroradiology, Toulouse University Hospital, Toulouse, France.

Timo Krings (T)

3Neurosurgery & Neuroradiology Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Vitor Mendes Pereira (VM)

3Neurosurgery & Neuroradiology Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Ajith J Thomas (AJ)

1Division of Diagnostic and Therapeutic Neuroradiology, St. Michael's Hospital, Toronto.

Thomas R Marotta (TR)

2Department of Medical Imaging & Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Christoph J Griessenauer (CJ)

10Department of Neurosurgery, Geisinger Health System, Danville, Pennsylvania; and.
11Research Institute of Neurointervention, Paracelsus Medical University, Salzburg, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH